Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patients.

Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patients.

AIMS: Current screening methods, such as single strand conformational polymorphism (SSCP) and denaturing high performance liquid chromatography (dHPLC) that are used for detecting mutations in familial hypercholesterolaemia (FH) subjects are time consuming, costly and only 80-90% sensitive. Here we...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Whittall, R, Scartezini, M, Li, K, Hubbart, C, Reiner, Z, Abraha, A, Neil, H, Dedoussis, G, Humphries, SE
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2010

Ижил төстэй зүйлс

Statins and familial hypercholesterolaemia.
-н: Neil, A, зэрэг
Хэвлэсэн: (2009)

DEVELOPMENT OF AN AFFORDABLE, SENSITIVE AND RAPID SCREENING METHOD FOR MUTATION DETECTION IN UK FH SUBJECTS
-н: Scartezini, M, зэрэг
Хэвлэсэн: (2008)

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
-н: Minhas, R, зэрэг
Хэвлэсэн: (2009)

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.
-н: Humphries, SE, зэрэг
Хэвлэсэн: (2006)

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic
-н: Futema, M, зэрэг
Хэвлэсэн: (2013)

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic.
-н: Futema, M, зэрэг
Хэвлэсэн: (2013)

The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
-н: Humphries, SE, зэрэг
Хэвлэсэн: (2005)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
-н: Marks, D, зэрэг
Хэвлэсэн: (2000)

The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men.
-н: Scartezini, M, зэрэг
Хэвлэсэн: (2007)

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
-н: Marks, D, зэрэг
Хэвлэсэн: (2003)

Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.
-н: Futema, M, зэрэг
Хэвлэсэн: (2014)

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study.
-н: Neil, H, зэрэг
Хэвлэсэн: (2000)

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
-н: Marks, D, зэрэг
Хэвлэсэн: (2002)

Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
-н: Marks, D, зэрэг
Хэвлэсэн: (2006)

Effect of statin treatment for familial hypercholesterolaemia on life assurance: results of consecutive surveys in 1990 and 2002.
-н: Neil, H, зэрэг
Хэвлэсэн: (2004)

Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening.
-н: Marks, D, зэрэг
Хэвлэсэн: (2003)

Familial hypercholesterolaemia.
-н: Gill, P, зэрэг
Хэвлэсэн: (2012)

Familial hypercholesterolaemia
-н: D.J. Blom
Хэвлэсэн: (2011-01-01)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
-н: Neil, H, зэрэг
Хэвлэсэн: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
-н: Neil, H, зэрэг
Хэвлэсэн: (2004)

Cardiovascular Disease Risk Estimation in Mutation Confirmed Familial Hypercholesterolaemia
-н: E. Ofagbor, зэрэг
Хэвлэсэн: (2023-12-01)

Cost-effectiveness analysis of the use of a high-intensity statin compared to a low-intensity statin in the management of patients with familial hypercholesterolaemia.
-н: Nherera, L, зэрэг
Хэвлэсэн: (2010)

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: A case-control study
-н: Talmud, P, зэрэг
Хэвлэсэн: (2013)

CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT
-н: Seed, M, зэрэг
Хэвлэсэн: (2011)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
-н: Neil, A, зэрэг
Хэвлэсэн: (2003)

EASILY MISSED? Familial hypercholesterolaemia
-н: Gill, P, зэрэг
Хэвлэсэн: (2012)

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
-н: Neil, H, зэрэг
Хэвлэсэн: (2003)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
-н: Neil, H, зэрэг
Хэвлэсэн: (2005)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
-н: Seed, M, зэрэг
Хэвлэсэн: (2009)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
-н: Seed, M, зэрэг
Хэвлэсэн: (2009)

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
-н: Talmud, P, зэрэг
Хэвлэсэн: (2013)

How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition?
-н: S.E. Humphries, зэрэг
Хэвлэсэн: (2023-12-01)

Familial Hypercholesterolaemia: An Updated Overall Management
-н: Mohd Kasim, Noor Alicezah, зэрэг
Хэвлэсэн: (2020)

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
-н: Vallejo-Vaz, Antonio J., зэрэг
Хэвлэсэн: (2020)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
-н: Neil, A, зэрэг
Хэвлэсэн: (2008)

Modelling a two-stage screen for autosomal dominant familial hypercholesterolaemia (FH) in UK Biobank
-н: J. Gratton, зэрэг
Хэвлэсэн: (2022-10-01)

Simplifying the detection of <it>MUTYH </it>mutations by high resolution melting analysis
-н: López-Villar Isabel, зэрэг
Хэвлэсэн: (2010-08-01)

Identification of FH-causing variants in patients with clinical familial hypercholesterolaemia recruited into the 100,000 genome project: preliminary analysis
-н: A. Rimbert, зэрэг
Хэвлэсэн: (2021-09-01)

Prevalence of familial hypercholesterolaemia (FH)-causing variants and impact on LDL-C concentration in European, South Asian, and African ancestry groups of the UK Biobank
-н: J. Gratton, зэрэг
Хэвлэсэн: (2023-12-01)

Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing.
-н: Starr, B, зэрэг
Хэвлэсэн: (2008)